Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

The FDA has approved Cobenfy, a new drug to treat people with schizophrenia that comes with fewer side effects.

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA ... New Drug Exemption applications), along with AI model developers and other firms in the drug development landscape.

Novo Nordisk said on Tuesday the U.S. FDA has approved its blockbuster drug Ozempic to lower the risk of progression of ...

In this interview, we explore the key changes shaping the pharmaceutical industry, maintaining compliance across global ...

Duxin Sun receives funding from the NIH, FDA ... reducing the costs of the current “test-and-see” approach to clinical trials. While AI alone might not revolutionize drug development, it ...

In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

A University of Oklahoma professor and his team have discovered a new way to put atoms into drug molecules that could revolutionize the drug industry. The safer, cheaper, more environmentally friendly ...